Literature DB >> 26121190

Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data.

Shivani A Patel, Munir Winkel, Mohammed K Ali, K M Venkat Narayan, Neil K Mehta.   

Abstract

BACKGROUND: Impressive decreases in cardiovascular mortality have been achieved through risk factor reduction and clinical intervention, yet cardiovascular disease remains a leading cause of death nationally.
OBJECTIVE: To estimate up-to-date preventable fractions of cardiovascular mortality associated with elimination and reduction of 5 leading risk factors nationally and by state in the United States.
DESIGN: Cross-sectional and cohort studies.
SETTING: Nationally representative and state-representative samples of the U.S. population. PARTICIPANTS: Adults aged 45 to 79 years. MEASUREMENTS: Self-reported risk factor status in the BRFSS (Behavioral Risk Factor Surveillance System) 2009-2010 was corrected to approximate clinical definitions. The relative hazards of cardiovascular death (International Classification of Diseases, 10th Revision, codes I00 to I99) associated with risk factors were estimated using data from NHANES (National Health and Nutrition Examination Survey) (1988-1994 and 1999-2004, followed through 2006).
RESULTS: The preventable fraction of cardiovascular mortality associated with complete elimination of elevated cholesterol levels, diabetes, hypertension, obesity, and smoking was 54.0% for men and 49.6% for women in 2009 to 2010. When the more feasible target of reducing risk factors to the best achieved levels in the states was considered, diabetes (1.7% and 4.1%), hypertension (3.8% and 7.3%), and smoking (5.1% and 4.4%) were independently associated with the largest preventable fractions among men and women, respectively. With both targets, southern states had the largest preventable fractions, and western states had the smallest. LIMITATION: Self-reported state data; mortality hazards relied on baseline risk factor status.
CONCLUSION: Major modifiable cardiovascular risk factors collectively accounted for half of cardiovascular deaths in U.S. adults aged 45 to 79 years in 2009 to 2010. Fewer than 10% of cardiovascular deaths nationally could be prevented if all states were to achieve risk factor levels observed in the best-performing states. PRIMARY FUNDING SOURCE: Robert Wood Johnson Foundation.

Entities:  

Mesh:

Year:  2015        PMID: 26121190     DOI: 10.7326/M14-1753

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  62 in total

1.  A Coaching by Telephone Intervention on Engaging Patients to Address Modifiable Cardiovascular Risk Factors: a Randomized Controlled Trial.

Authors:  Eugene Z Oddone; Jennifer M Gierisch; Linda L Sanders; Angela Fagerlin; Jordan Sparks; Felicia McCant; Carrie May; Maren K Olsen; Laura J Damschroder
Journal:  J Gen Intern Med       Date:  2018-05-07       Impact factor: 5.128

Review 2.  Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Authors:  Roopesh S Gangwar; Sanjay Rajagopalan; Rama Natarajan; Jeffrey A Deiuliis
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 2.689

3.  Coverage and Access for Americans with Cardiovascular Disease or Risk Factors After the ACA: a Quasi-experimental Study.

Authors:  Ameen Barghi; H Torres; N R Kressin; D McCormick
Journal:  J Gen Intern Med       Date:  2019-06-27       Impact factor: 5.128

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

5.  Does Identification of Previously Undiagnosed Conditions Change Care-Seeking Behavior?

Authors:  Rebecca M Myerson; Lisandro D Colantonio; Monika M Safford; Elbert S Huang
Journal:  Health Serv Res       Date:  2017-01-10       Impact factor: 3.402

Review 6.  Uses of Arterial Stiffness in Clinical Practice.

Authors:  Ian B Wilkinson; Kaisa M Mäki-Petäjä; Gary F Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-02-27       Impact factor: 8.311

7.  Preventing Disability: The Influence Of Modifiable Risk Factors On State And National Disability Prevalence.

Authors:  Neil K Mehta; Shivani A Patel; Mohammed K Ali
Journal:  Health Aff (Millwood)       Date:  2017-04-01       Impact factor: 6.301

8.  Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention.

Authors:  Steven P Dehmer; Michael V Maciosek; Amy B LaFrance; Thomas J Flottemesch
Journal:  Ann Fam Med       Date:  2017-01-06       Impact factor: 5.166

9.  A risk score assessment tool for peripheral arterial disease in women: From the National Health and Nutrition Examination Survey.

Authors:  Hend Mansoor; Islam Y Elgendy; Renessa S Williams; Verlin W Joseph; Young-Rock Hong; Arch G Mainous
Journal:  Clin Cardiol       Date:  2018-08-17       Impact factor: 2.882

10.  Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy.

Authors:  Chuanrui Ma; Wenwen Zhang; Xiaoxiao Yang; Ying Liu; Lipei Liu; Ke Feng; Xiaomeng Zhang; Shu Yang; Lei Sun; Miao Yu; Jie Yang; Xiaoju Li; Wenquan Hu; Robert Q Miao; Yan Zhu; Luyuan Li; Jihong Han; Yuanli Chen; Yajun Duan
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.